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Abstract
The Metagenomics and Metadesign of the Subways and Urban Biomes (MetaSUB) International Consortium is a
novel, interdisciplinary initiative comprised of experts across many fields, including genomics, data analysis, engineering,
public health, and architecture. The ultimate goal of the MetaSUB Consortium is to improve city utilization and planning
through the detection, measurement, and design of metagenomics within urban environments. Although continual
measures occur for temperature, air pressure, weather, and human activity, including longitudinal, cross-kingdom
ecosystem dynamics can alter and improve the design of cities. The MetaSUB Consortium is aiding these efforts by
developing and testing metagenomic methods and standards, including optimized methods for sample collection, DNA/
RNA isolation, taxa characterization, and data visualization. The data produced by the consortium can aid city planners,
public health officials, and architectural designers. In addition, the study will continue to lead to the discovery of new
species, global maps of antimicrobial resistance (AMR) markers, and novel biosynthetic gene clusters (BGCs). Finally, we
note that engineered metagenomic ecosystems can help enable more responsive, safer, and quantified cities.
Keywords: Microbiome, Biosynthetic gene clusters, Built environment, Next-generation sequencing, Antimicrobial
resistance markers
Introduction
In the past few years, novel work has characterized
the microbiota and metagenome of urban environ-
ments and transit systems and demonstrated species-
specificity to certain areas of a city, “molecular
echoes” of environmental events, and even a forensic
capacity for geospatial metagenomic data [1–8]. These
data are especially helpful for understanding the sites
of greatest points of contact between humans and the
microbial world within cities, such as their subways
or mass-transit systems [1–3, 7]. Indeed, how humans
interact with (or acquire) new species of bacteria and
other organisms depends on the environment they
transit, the types of surfaces they touch, and the
physical dynamics of their environment in their city.
While a wide variety of methods, protocols,
algorithms, and approaches for such large-scale stud-
ies are available for researchers, best practices, nor-
malized methods, and ideal taxonomic approaches for
global work are still being developed to ensure data
quality and the promotion of robust data interpret-
ation [9–12].
Since the majority of the world’s population (54 %) cur-
rently resides in cities, the use of integrative functional
genomic methods to elucidate the molecular dynamics
(DNA, RNA, proteins, and small molecules) and ecosys-
tems of cities has potentially large implications for the sus-
tainability, security, safety, and future planning of cities
[13]. This includes the concept of “smart cities,” which
could detect and respond to pathogens, improve water
safety and treatment, and track the ever-changing metage-
nomic complexity of urban environments [14–17]. Indeed,
by establishing a baseline genomic profile for a city, it is
then possible to create differentials and density maps of
organisms relevant for the built environment, such as
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mold and insects [18], as well as the ability to discern the
impact of temperature, pressure, humidity, building mate-
rials, and other factors into the movement of organisms
across a city. However, integrating the many disparate
types of data generated from entire cities requires an
interdisciplinary approach bringing together experts in en-
gineering, public health, medicine, architecture, microbiol-
ogy, metagenomics, bioinformatics, biochemistry, data
science, functional genomics, virology, architectural de-
sign, and the built environment. Thus, in order to bridge
these disciplines and work across cities with global stan-
dards and approaches, in 2015, we initiated the Metage-
nomics and Metadesign of Subways and Urban Biomes
(MetaSUB) International Consortium.
Beyond the taxonomic classification and stratification
of known and novel species that span a city, these data
can be mined for other purposes. This includes charac-
terizing novel markers for antimicrobial resistance
(AMR), as well as biosynthetic gene clusters (BGCs),
which can discern and validate the small molecules
encoded by these organisms’ genomes and dynamically
regulated transcriptomes [19, 20]. Since bacteria use
small molecules to mediate microbial competition, mi-
crobial cooperation, and environment sensing and adap-
tation, we hypothesize that identifying the suite of small
molecules produced by bacteria that are living in urban
areas will reveal hidden traits of their adaptation to their
successful colonization of variegated surfaces [21]. Sev-
eral small molecules have been previously isolated from
thermophilic and halophilic bacteria, providing a first
glance of the metabolic capacity of extremophiles. These
include antibacterial molecules, thought to confer a
competitive advantage in harsh environments, and side-
rophores, which act as molecular “scavengers” of trace
metals in limited conditions [22, 23]. Thus, MetaSUB’s
global concerted efforts to map “urban genomes” is not
only a window into urban biological systems but also a
concomitant search for novel drugs, antibiotics, and
small molecules that may provide new avenues for drug
development and design.
2015 inaugural meeting of the MetaSUB
Consortium
The Inaugural MetaSUB Meeting was sponsored by the
Alfred P. Sloan Foundation and held on June 20, 2015,
at the New York Genome Center (NYGC), following the
Microbes in the City Conference on June 19, 2015, at
the New York Academy of Sciences. This represented
the first gathering and open meeting of the MetaSUB
International Consortium. We had 30 speakers repre-
senting a wide array of expertise and disciplines, from
microbiology and genomics to building/subway design
and metadata collection. The meeting had 139 regis-
trants from over 14 countries, and many speakers and
attendants noted that this represented the “coming out
of the shadows” of the microbes in our cities and the be-
ginning of using these data to make cities quantified and
more integrated [24, 25]. The meeting also featured a
key discussion about the promises and pitfalls of meta-
genomics analysis, including a discussion of some of the
first metagenomic data collected in NYC, Hong Kong,
and Boston subways [1–3, 26].
To organize the goals of the Consortium, five working
groups convened, led by five moderators. The sessions
included (1) Sample Collection and Metadata led by
Lynn Schriml, Ph.D., University of Maryland School of
Medicine; (2) Sample Processing and Sequencing led by
Daniela Bezdan, Ph.D., Center for Genomic Regulation
in Spain; (3) Bioinformatics Analytics led by Brian Kidd,
Ph.D., Icahn School of Medicine at Mount Sinai; (4)
Visualization and Interpretation led by Elizabeth Hénaff,
Ph.D., Weill Cornell Medicine; and (5) Ethical and Social
Challenges led by Nathan Pearson, Ph.D., New York
Genome Center. The summaries of these discussions
have been outlined below and are also posted on the
study’s website (www.metasub.org). The results of these
working group discussions have built the foundations of
MetaSUB, as each working group dealt with a key chal-
lenge the MetaSUB consortium will have to address with
this global study. These working groups will evolve into
committees that members of the consortium can sit on
and lead. All the work by these committees will be
reviewed by an external advisory board (EAB) made up
of experts in the fields of bioinformatics, virology,
microbiology, immunology, genomics, and mass transit.
This includes Elodie Ghedin, Ph.D., New York Univer-
sity, Timothy Read, Ph.D., Emory University, Claire Fra-
ser, Ph.D., University of Maryland School of Medicine,
Joel Dudley, Ph.D., Icahn School of Medicine at Mount
Sinai, Mark Hernandez, PE, Ph.D., University of Color-
ado, and Christopher Bowle, Ph.D., Institut de Biologie
de l’Ecole Normale Supérieure.
Summary of key points from working groups
Sample collection and metadata
Any large-scale collection effort requires a detailed proto-
col and test of best practices, which was a key focus of the
meeting. The discussion highlighted a number of chal-
lenges and suggestions related to sampling methods,
standardization of protocols for data collection and pro-
cessing, and validation and comparability of metadata.
Also, some of the questions regarding MetaSUB collec-
tions spanned a range of unknown aspects of urban
microbiomes. This ranged from the regularity of metage-
nomic species compositions (across time and space), the
sensitivity of a surface to harboring bacteria or DNA in
the context of weather, temperature, humidity, usage, and
other metadata, the thresholds for persistence, the
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biochemical and biological functions of organisms as a
function of their location, and the different methods for
air vs. surface collection. The significant results of this
working group are the following:
 There should be a standardized protocol for
sampling across all the MetaSUB cities, reducing
variability, as has been done for the FDA’s
Sequencing Quality Control Consortium, the
Genome in a Bottle Consortium, and the
Metagenomics Standards Groups like the Earth
Microbiome Project [9, 10, 27–30].
 Several series of controlled experiments should be
conducted to determine what factors impact the
quality of the samples, specifically, the DNA yield
and potentially diversity of samples (e.g., number of
passengers, humidity, air flow, temperature,
sampling devices, sample storage)
 Establish a standard way to assess cleaning
treatment of the different subway systems.
 Both surface-based and air sampling should be con-
ducted in each of the city transit systems.
 The sampling protocol and metadata selection
should be based on a hypothesis-driven and
question-based approach that can be uniform across
all cities.
 Design the most effective and efficient data
collection application (“app”) that will be functional
in all cities, store the metadata, upload it onto a web
database, and integrate with geospatial data to create
a map of collections. These include the fields of
Table 1.
Sample processing and sequencing
A key challenge in metagenomic studies is to obtain a
representative picture of heterogeneous environmental
samples and to avoid sample processing-based biases
when comparing samples collected at different sites and
time points. In theory, DNA isolated from a metage-
nomic sample should represent the biodiversity in
complex populations. In reality, the quality of the infor-
mation that can be generated and analyzed is highly
dependent on how the samples have been collected,
stored, and processed. Therefore, the goal of this work-
ing group is to (1) define standards for sample swabbing,
storage, DNA extraction, sequencing library preparation
and sequencing, (2) benchmark available sample pro-
cessing methods, (3) survey the reproducibility of proto-
cols at different centers, and (4) communicate defined
standards to MetaSUB collaborators and the public. To
this end, advantages, limitations, and potential issues of
available swabbing, DNA extraction, and library prepar-
ation methods need to be investigated, and candidate
methods need to be benchmarked on diverse sample
types.
Table 1 Data fields for MetaSUB mobile data collection
Category # of fields Fields, with input from OSBSS metadata
MetaSUB data type 15 Soil, Superfund site, waterway, land/sea/air interface, subway, marine wild-life, synthetic
ecologies, cockroach, bedbug, pigeon, rat, worm, lab mice, NYC homes, sewage
Surface composition 9 Metal, wood, plastic, ceramic, leather, concrete, glass, other
Surface type 8 Kiosk, turnstile, bench, railing, handrail, garbage can, payphone, other
Surface porosity 3 Hermetically sealed, porous, absorbent
Cleaning frequency 1 Frequency per day
Cleaning type 1 Text for detergent or methods used
Human activity 3 Video, IR, and observational estimates of # of people
Air vents 3 Number of input and output vents
Subway lines 22 1, 2, 3, 4, 5, 6, 7, A, C, E, B, D, F, M, G, J, Z, L, S, N, Q R
Subway stations 468 Auto-complete from form
Subway car position 3 First car, N + l car, last car
Train ID 1 Train# 4673
Temperature 1 Range from −50°F to 15 CTF
Humidity 1 Range from 0 to 100 %
Park surfaces 9 Bench, handrailing, water fountain, slide, monkey bars, swings, trash can, lamp post, other
Audio 3 Record, play, delete
Geotag and time 1 GPS-coordinates (longitude and latitude) and time-stamp
Photograph 1 iOSor android-based
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A main issue for sample processing is the heterogen-
eity of environmental samples. MetaSUB swabs will dif-
fer in DNA content and quality as well as microbiome
composition, i.e., contain variable fractions of gram-
negative and gram-positive bacteria, viral, fungi, and
other populations of organisms. Variable susceptibility of
cell structures to lytic reagents will introduce biases dur-
ing DNA extraction. In addition, many microorganisms
are present in the form of spores, which demonstrate
high resistance to lytic practices [31]. The heterogeneous
sample aggregates will range from solid to liquid, and
are in most cases temperature, pH, and oxygen sensitive.
Therefore, it is crucial to take parameters of the sample
habitat and conditions like temperature, pH, or salinity
into account for optimal selection of sample processing
and library preparation methods (see Table 1 for col-
lected data fields) or to account for introduced biases
during statistical analysis of the sequencing data.
Sample swabbing and storage
Since cotton swabs could lead to significant contamin-
ation with cotton DNA during extraction, we first con-
cluded that plant-based collection media would be
avoided. Thus, collections should use the previously-
utilized, nylon-flocked swabs (Copan Liquid Amies
Elution Swabs 480C), retained in 1 ml transport
medium. Minimal generation times of microorganisms
range from a few minutes to several weeks [32]. There-
fore, to avoid growth bias, environmental samples
should be kept on ice during transportation to preserve
their initial species composition. Samples are stored at
−20 °C or below. Workbenches and non-sterile materials
must have been cleaned with bleach and ethanol to
avoid any cross-contamination.
DNA extraction
Two ways to extract DNA have been proposed: (1) dir-
ect extraction of DNA in situ by lysis of the bacterial
cells within the sample and (2) indirect extraction by
separation of bacterial cells from other organic and inor-
ganic materials followed by DNA extraction. One of the
main disadvantages of the direct extraction methods is
the elevated risk of contamination with humic acids,
proteins, polysaccharides, lipids, minerals, non-bacterial
DNA, and minerals. Those contaminations can be diffi-
cult to remove and can inhibit chemical and enzymatic
steps required for DNA processing and library prepar-
ation. On the other hand, the indirect extraction of
DNA by extraction of bacterial cells from the sample
likely leads to an incomplete representation or bias in
content measures of bacterial species within the sample
[33]. Thus, MetaSUB currently plans to use direct DNA
extraction protocols, such as MoBio PowerSoil kit.
However, we will also compare and test various extrac-
tion protocols, combining mechanical, chemical, and en-
zymatic lyses steps for the several reasons. Mechanical
methods like bead-beating homogenizations, sonifica-
tion, vortexting, and thermal treatments like freezing-
thawing or freezing-boiling tend to yield the most
comprehensive access to DNA from the whole bacterial
community as they allow to expose DNA from bacteria
in micro-aggregates and spores. Extensive physical treat-
ment could lead to DNA shearing resulting in fragments
ranging from 600 to 12 kb, which, while not a problem
for short fragment sequencing techniques (e.g., Illumina
HiSeq) but would be problematic for long-read tech-
nologies (e.g., Pacific Biosciences, Oxford Nanopore
MinION). Chemical cell disruption by detergents is an-
other widely used technique. The most commonly
employed chelating agents are SDS, EDTA, Chelex 100,
and various Tris- and Natrium phosphate buffers. Other
chemical reagents like cetyltrimethyl-ammonium bromid
(CTAB) are able to remove humic acid to some extend.
Humic acid contaminations are problematic since they
share similar chemical and physical characteristics like
DNA and co-purified humic acids also interferes with
the DNA quantification, since they exhibit absorbance
between 230 and 260 nm as well. Finally, enzymatic
methods complement mechanical and chemical tech-
niques by disrupting cell walls of gram-positive bacteria,
which tend to be resistant to physical stress. In addition,
they facilitate removal of RNA and protein contamina-
tions, even though single-stranded and double-standed
RNA viruses are an important component of the meta-
genomic profiles (ongoing efforts are being to made to
get all of these as well). Most commonly used enzymes
are lysozymes, RNase, and proteinase K (2015).
Currently, members of the consortium are testing a
new enzyme cocktail for DNA extraction consisting of
lysozyme, mutanolysin, achromopeptidase, lysostaphin,
chitinase, and lyticase (Fig. 1), which so far show
improved yields across multiple commonly used kits
for metagenomics extraction.
Sequencing library preparation
The current gold standard for metagenomic sequencing
is based on paired-end sequencing on the Illumina
HiSeq (2500 or 4000) using 100 to 150 bp paired reads.
Longer reads of up to 300 bp as produced by the MiSeq
increase specificity of read alignments and hence im-
prove identification of bacterial species. However, the
substantial increase in per-base cost of sequencing leads
to lower depth-of-coverage and can dramatically reduce
the detectability of bacterial populations contained in
very small fractions. Long-read sequencing technologies
(Pacific Bioscience SMRT and Oxford Nanopore
MinION) promise to substantially improve classification
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of bacterial DNA by simplifying de novo assembly of
novel species and by allowing to span complete operons
and bridging long repeats with a single read. The Roche
454 platform, which has been a cornerstone of metage-
nomics in several studies, has not been considered here,
as the technology has been discontinued. Based on these
considerations, we concluded that all MetaSUB samples
will be sequenced using the Illumina HiSeq platform
and 150 bp paired-end reads. The application of long-
read technologies will be tested on a subset of samples,
and results will be benchmarked based on short read re-
sults. Finally, the inclusion of a positive control sample
with known bacterial and metagenomic samples present
was recommended, such as those from the Genome Ref-
erence Consortium (GRC) and US National Institute of
Standards and Technology (NIST).
Bioinformatics analytics
With the advent of citizen science, crowdsourcing, and
participatory international coordination of sampling, the
ability to collect large metagenomic datasets from our sur-
roundings is no longer the limiting factor in scientific dis-
covery and exploration of the microbial landscape in
urban environments [35]. As the tide has shifted, key
questions about ideal methods to analyze and process the
data have become paramount, and multiple analytical
challenges have arisen for computing, processing, and
sharing of metagenomic data [12]. Addressing these ana-
lytical challenges has implications for how we understand
and interpret the diversity and complexity of urban bi-
omes. The bioinformatics working group discussed
current analytical challenges facing the consortium and
suggests protocol adaptations as technologies improve.
What emerged from the discussion were four themes
covering (1) standards, (2) reproducibility, (3) open-
access/data sharing, and (4) innovation. The central goal
of the bioinformatics working group is to build on these
themes over time, refining the methods, because as it
currently stands, there is not a definitive set of guidelines
for many of these challenges.
Sample standardization for benchmarking analytical tools
and interpreting results
A key challenge in analyzing metagenomic sequences
from urban environments is how to deal with potential
novelty and sequence diversity. Metagenomic sequen-
cing provides an unprecedented wealth of data, and
probing the urban biome pushes the frontiers of our
knowledge and understanding of microbes. It is thus
critical to have empirical and computational standards
to delineate the technical issues from true discoveries.
An empirical way to address this challenge is to extrane-
ously introduce standard control samples that have been
well characterized to help interpret findings and place
discoveries in context. Another approach is to generate
reference data sets from various sequencing technologies
that bioinformaticians and developers can use for testing
and benchmarking [34]. These reference sequence sets
provide ideal test cases for understanding technical is-
sues with sequencing data or algorithms (given the
known proportions of various bacteria) and supply use-
ful benchmarks for consortium members during the de-
velopment of new tools [1]. More importantly, these
references serve as standards for developing clear
Compliments of the ABRF Metagenomics Research Group
Fig. 1 Performance of new metagenomics enzyme cocktail. We used replicate samples for a range of different extraction kits with (red) and without
(blue) the polyzyme mixture (x-axis) and examined the yield of DNA from the extraction (y-axis). Samples include Halobacillus (Hal), Escherichia coli (EC),
soil samples, yeast, sea ice, and a wine trub for the Omega Mullusc Kit (OM), Norgen Soil Kit (N), and the Standard CTAB-Phenol protocol (ST)
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metrics on how to evaluate and interpret results from
metagenomic analyses from large numbers of people
[35].
Data processing and reproducibility
The massive scale and volume of metagenomic data gen-
erated in studies of the urban biome exceeds our ability
to conduct manual processing and quality assurance.
Computational processing can alleviate this bottleneck,
and it is important to develop clear quality control
metrics for each link in the analytical chain (data QC,
post-sequencing trimming, alignment, assembly, phylo-
genetics, summary statistics). As sample preparation and
processing strongly influence what information can be
extracted and analyzed, it is important to have strong
collaborations between the computational biologists who
develop the computational tools and the core facilities
or labs that create the libraries and process samples for
sequencing, as well as methods to detect, and correct,
for batch effects [36].
Code sharing and transparency are important features
of reproducibility, and open source tools such as R and
Bioconductor exist for creating processing pipelines. It is
important to create transparent workflows that can be
cloned and deployed on remote machines so the ana-
lyses can be reproduced with minimal effort [37]. Fur-
thermore, electronic notebooks with protocols can be
linked with publications. Having version control or
Docker-style tracking encourages collaboration and en-
ables best practices to spread through the community of
developers and scientists. Other large-scale consortiums
such as The Cancer Genome Atlas (TCGA) and Human
Microbiome Project (HMP) have successfully navigated
these issues and provided a model for creating accessible
data portals with community-based tools [38, 39]. In this
age of abundant computing and storage, data proven-
ance and transparency are critical for developing robust
and useful methods that enable innovation while main-
taining scientific rigor.
Data sharing and common formats
Collecting samples and generating data can be an expen-
sive effort, yet these data sets are rich and can be lever-
aged when others have access to data. As a community,
we want to encourage open collaboration and provide
incentives for researchers to share their published data
in a common format that facilitates interoperability (e.g.,
SAGE, HMP guidelines). We can better understand how
microarray technology has matured and the data ware-
houses that have sprung up around the developing tech-
nology. Central clearing houses like the Gene Expression
Omnibus (GEO) and European Genome-phenome Arch-
ive (EGA) include standard data fields and associated
metadata that are compliant with Minimum Information
About a Microarray Experiment (MIAME) guidelines
[40–42]. These resources have accelerated research and
collaborations by providing accessible data sets for de-
veloping novel methods and addressing new scientific
questions, which are linked with the original contribu-
tion [43]. Additionally, the analysis of public data has
generated many new insights and hypotheses that would
not have been identified or proposed otherwise [44].
Ideally, these data sharing portals offer ways to link new
insights and results back to their original source. These
data warehouses establish a strong foundation for other
scientists, citizens, and policy makers to develop new re-
search strategies based on the accumulated knowledge.
Innovation
Technological and computational innovations will con-
tinue to define and drive investigations of urban biomes
across all MetaSUB sites (Table 2). These advances cre-
ate an apparent tension between being the cutting edge
where analyses and conclusions are more fluid, and well-
established processes that are robust and strongly sup-
ported. It is crucial to distinguish between these two
modes and the computational tools that underpin them.
We want to encourage the development of novel
methods and work toward best practices that result in
accepted pipelines that serve as a strong foundation for
scientific discovery.
Data visualization and interpretation
Visualization and interpretation are some of the most
challenging aspects of a study this large and global.
Thus, the working group outlined the goals of the con-
sortium according to three main areas. First, there is a
need to design systems of data visualization for data ex-
ploration, so that any user of the web site or resources
can rapidly learn from and utilize the data [1]. Second,
there must be a clear outline of the consortium
organization (Fig. 2), including an ability to look at re-
sults, metadata, and milestones for each city. Third,
there is a need for communicating results, collaboration,
publications, and the status of outreach and citizen sci-
ence efforts. This will continue to use the components
of web sites, online forums, and social media such as
Twitter, Facebook, and Instagram.
Each of these categories holds its own challenges and
specifications, for example, visualizations for data ex-
ploration need to be much denser in information than
for publication where only the information relevant to
the message needs to be presented. Visualizations for
outreach need to be friendly and easy to understand by
non-scientists and laypeople. The medium available also
influences design choices: figures designed for print
media have limitations that the web does not, and we
have already piloted a cross-kingdom browser for urban
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Table 2 Hub laboratories of the MetaSUB International Consortium
City details Site principal investigator
Site City Country Department University/institute Contact PIs Email
1 Buenos Aires Argentina 1. Genetics and Genomic Sciences; 2
Computational Biology Center; 3.
Departamento de Fisica
1. Icahn School of Medicine at Mount
Sinai; 2 IBM; 3. University of Buenos Aires
Gustavo Stolovitzky1,2/Ariel
Chernonetz3
gustavo@us.ibm.com/achernomoretz@
leloir.org.ar
2 Sydney Australia Computational Metagenomics University of Technology Aaron Darling/Catherine Burke aaron.darling@uts.edu.au/Catherine.
Burke@uts.edu.au
3 Vienna Austria Bioinformatics/Bioinformatics Boku University Vienna/University of
Applied Sciences
Paweł P. Łabaj/Alexandra Graf pawel.labaj@boku.ac.at/alexandra.
graf@fh-campuswien.ac.at
4 Ribeirão Preto Brazil Department of Genetics, Laboratory of
Epigenomics and Bioinformatics
University of Sao Paolo Houtan Noushmehr houtan@usp.br
5 Rio Da Janeiro Brazil Oswaldo Cruz Institute FIOCRUZ Milton Ozorio Moraes milton.moraes@fiocruz.br
6 São Paulo Brazil Medical Genomics AC Camargo Cancer Center Emmanuel Dias-Neto emmanuel@cipe.accamargo.org.br
7 Santiago Chile Universidad del Desarrollo Juan Ugalde jugalde@udd.cl
8 Beijing China Beijing Children's Hospital/Translational
Bioinformatics Research Institute
Capital Medical University/Capitalbio Corp Yongli Guo/Yiming Zhou ylgyongliguo@163.com/yimingzhou@
capitalbio.com
9 Guangzhou China 1. Zhongshan ophthalmic Center,
Center for Precision Medicine;
2. Department of Environmental Health;
3. Division of Laboratory Medicine at
Zhujiang Hospital
1. Sun Yat-sen University; 2.Southern
Medical University
Zhi Xie1,1/Daisy Zheng2,2/
Hongwei Zhou2,3
xiezhi@gmail.com/180553957@qq.com/
811807859@qq.com
10 Hong Kong China School of Energy and Environment City University of Hong Kong Patrick K.H. Lee patrick.kh.lee@cityu.edu.hk
11 Shanghai China School of Life Science Fudan University Leming Shi/Sibo Zhu/Anyi
Tang
lemingshi@fudan.edu.cn/sibozhu@fudan.
edu.cn/491269854@qq.com
12 Bogota Colombia Molecular Genetics Corporación Corpogen Carlos A. Ruiz-Perez/Maria M.
Zambrano
cruiz_perez@hotmail.com/mzambrano@
corpogen.org
13 Zagreb Croatia Department of Microbiology University of Zagreb Tomislav Ivanković tomislav.ivankovic@biol.pmf.hr
14 Cairo Egypt Department of Biology American University of Cairo Rania Siam rsiam@aucegypt.edu
15 Marseille France Department of Virology Aix-Marseille University Nicolas Rascovan nicorasco@gmail.com
16 Paris France Laboratory of Computational and
Quantitative Biology
Sorbonne Universite's, University Pierre et
Marie Curie Univ. Paris 06, CNRS, Institut
de Biologie Paris-Seine
Hugues Richard/Ingrid
Lafontaine
hugues.richard@upmc.fr/ingrid.
lafontaine@upmc.fr
17 Berlin Germany Public Health Robert Koch Institute Lothar H. Wieler/Torsten
Semmler
wielerlh@rki.de/SemmlerT@rki.de
18 Hyderabad India Department of Biotechnology and
Bioinformatics
University of Hyderabad/Noble Foundation/
ClonzBio Tech
Niyaz Ahmed/Bharath
Prithiviraj/Narasimha Nedunuri
ahmed.nizi@gmail.com/bharath.
prithiviraj@gmail.com/narasimha.
nedunuri@clonzbio.com
19 New Delhi India Computational Biology Memorial Sloan Kettering Sikander Hyat hayat221@gmail.com
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Table 2 Hub laboratories of the MetaSUB International Consortium (Continued)
20 Tehran Iran Ecology/Medical Sciences American Museum of Natural History/
Ministry of Science
Shaadi Mehr/Kambiz
Banihashemi
smehr@amnh.org/kbanihashemi@
yahoo.com
21 Rome Italy Molecular Biology Section Army Medical and Veterinary Research
Center
Florigio Lista/Anna Anselmo romano.lista@gmail.com/
annanselm@gmail.com
22 Sendai Japan Institute for Advanced Biosciences Keio University Haruo Suzuki haruo@sfc.keio.ac.jp
23 Tokyo Japan Institute for Advanced Biosciences Keio University Haruo Suzuki haruo@sfc.keio.ac.jp
24 Mexico City Mexico National Institute of Public Health IANPHI Mexico Secretariat Celia M. Alpuche Aranda/Jesus
Martinez
celia.alpuche@insp.mx/jmbarnet@
insp.mx
25 Auckland,
Hamilton and
Rotorua
New
Zealand
Environmental Research Institute Univeristy of Waikato Ayokunle Christopher Dada cdada@waikato.ac.nz
26 Lagos Nigeria Microbiology University of Lagos Folarin Oguntoyinbo foguntoyinbo@unilag.edu.ng
27 Oslo Norway Protection and Societal Security
Division
Norwegian Defense Research
Establishment FFI
Marius Dybwad marius.dybwad@ffi.no
28 Lisbon Portugal Department of Biology, i3S Population
Genetics and Evolution Group
University of Porto Manuela Oliveira/Andreia
Fernandes
manuelao@ipatimup.pt/afernandes@
ipatimup.pt
29 Porto Portugal Department of Biology, i3S Population
Genetics and Evolution Group
University of Porto Manuela Oliveira/Andreia
Fernandes
manuelao@ipatimup.pt/afernandes@
ipatimup.pt
30 Doha Qatar Ecology/Medicine Weill Cornell Medical College - Qatar Aspassia D. Chatziefthimiou/
Salama Chaker
a.chatziefthimiou@richenvironments.com/
salama.b.chaker@gmail.com
31 Moscow Russia Bioinformatics Moscow Institute of Physics and
Technology, Institutskii Per. 9, Moscow
Region, Dolgoprudny 141700, Russia
Dmitry Alexeev/Dmitry
Chuvelev
alexeev@knomics.ru/dch@knomics.ru
32 Singapore Singapore Biochemistry and Molecular Biology Pennsylvania State University Stephan Schuster scschuster@ntu.edu.sg
33 Johannesburg South
Africa
Data Driven Healthcare IBM Research-Africa Geoffrey H Siwo gsiwo@za.ibm.com
34 Seoul South
Korea
Microbiology/Institute for Allergy and
Immunology/Cancer Risk Appraisal &
Prevention Branch
Institut Pasteur Korea/Korea University
College of Medicine/National Cancer
Center
Soojin Jang/Sung Chul Seo/
Sung Ho Hwang
soojin.jang@ip-korea.org/sungchul_
seo@korea.ac.kr/9954074@daum.net
35 Barcelona Spain Genomic and Epigenomic Variation 1. Center for Genomic Regulation (CRG),
The Barcelona Institute of Science and
Technology, Dr. Aiguader 88, Barcelona
08003, Spain 2. Universitate Pompeu
Fabra (UPF), Barcelona, Spain
Stephan Ossowski1,2/Daniela
Bezdan1,2
Stephan.Ossowski@crg.eu/bezdan.
daniela@googlemail.com
36 Stockholm Sweden Department of Molecular Biosciences,
The Wenner-Gren Institute
Stockholm University Klas Udekwu/Per O. Lungjdahl klas.udekwu@su.se/per.ljungdahl@su.se
37 Zurich Switzerland Institute of Molecular Life Sciences University of Zurich Olga Nikolayeva olga.nikolayeva@gmail.com
38 Izmir Turkey Department of Biostatistics and Medical
Informatics
Acibadem University Ugur Sezerman sezermanu@gmail.com
39 Sheffield UK Department of Animal & Plant Sciences University of Sheffield Eran Elhaik e.elhaik@sheffield.ac.uk
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Table 2 Hub laboratories of the MetaSUB International Consortium (Continued)
40 Montevideo Uruguay Informatik ETH Zurich Gaston Gonnet gonnet@ethz.ch
41 Baltimore USA Institute for Genome Sciences University of Maryland School of
Medicine
Emmanuel Mongodin emongodin@som.umaryland.edu
42 Boston USA Biostatistics Harvard T.H. Chan School of Public
Health
Curtis Huttenhower chuttenh@hsph.harvard.edu
43 Chicago USA Microbial Ecology Argonne National Laboratory Jack Gilbert gilbertjack@uchicago.edu
44 Denver USA Mechanical Engineering University of Colorado Mark Hernandez mark.hernandez@colorado.edu
45 Fairbanks USA Institute of Arctic Biology University of Alaska Fairbanks Elena M. Vayndorf elena.vayndorf@alaska.edu
46 New York City USA Physiology and Biophysics Weill Cornell Medicine Christopher Mason chm2042@med.cornell.edu
47 Sacramento USA Department of Ecology and Evolution UC Davis Jonathan Eisen jonathan.eisen@gmail.com
48 San Francisco USA Department of Interdisciplinary Arts and
Sciences
University of California, Davis Christopher Beitel chris.w.beitel@gmail.com
49 Seattle USA Department of Genetics and Genomics University of Washington David Hirschberg dhberg@uw.edu
50 Washington DC USA Institute for Genome Sciences University of Maryland School of
Medicine
Lynn Schriml lschriml@som.umaryland.edu
51 London UK Department of Twin Research Kings College London Frank Kelly/Sarah Metrustry frank.kelly@kcl.ac.uk/sarah.metrustry@
kcl.ac.uk
We show the city, country, site of collaboration (university, company, or government agency), principal investigator (PI), and the number of riders per year in the targeted mass-transit system. This includes the top busi-
est subways in the world, except for Moscow (still recruiting PI)
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metagenomics (www.pathomap.org/map) [1]. In addition
to visualizing scientific data, we will use visual represen-
tations to aid in the coordination and organization of
the consortium, e.g., metadata regarding the number of
samples collected and processed in each site. Finally, the
kind of data will dictate the design of the visualizations.
Such data include metadata taxa present (phylogenetic
relationships and abundance), metabolic pathways, func-
tional annotations, geospatial relationships, and time-
lapse data. Finally, metadata outlined in Table 1 will also
be integrated into the design of these visuals, since the
metadata from a study can readily become the raw data
for a follow-up study.
Ethical, social, and legal challenges
Since the MetaSUB Consortium is a public, transparent,
and open consortium that aims to characterize and dis-
cover the microbial sides of the cities in which we live,
transparency is an important principle during the
process of urban biome discovery, hands-on education,
and city planning. Therefore, all meeting minutes, talk
slides, and group listserv correspondences are posted in
public archives and also on the Consortium website.
Also, any grant dollars, donations, and corporate spon-
sorship are listed and detailed publicly as well.
Nonetheless, there are several critical ethical and social
challenges that must be addressed. First, the collection
of samples must be done in a transparent and assuring
fashion, and work from the first studies included busi-
ness cards to hand out to citizens on the street for when
they had questions. Interactions from the public ranged
from curiosity and extreme interest about the project to
confusion of what would be found. In general, because
the first data sets have shown a predominance of harm-
less and commensal bacteria, it is important to note the
data-based assurance to the public safety and trust in
public transportation. Nonetheless, there have been les-
sons learned from the “cautionary tale” of DNA found in
NYC metagenomic data sets [12], wherein fragments of
DNA that matched a pathogen must be put into the
context of virulence markers and also in the context of
likelihood of the samples being present. Finally, these
first urban metagenome reports also show that the col-
lection, interpretation, and release of such public data
represent an extremely serious responsibility for the sci-
entists reporting and interpreting these sensitive data.
Also, consideration of other logistical challenges re-
lated to the interpretation and release of the data and
analysis are required, regarding city, transit, and health
authorities in each city. Some cities may wait until data
are published before deciding to comment, but nonethe-
less, all data and manuscripts should be shared with city
officials beforehand, and this has been the standard ap-
plied thus far [1]. Also, three new guidelines have been
implemented as part of MetaSUB: all data and sequences
collected will be given to the local authorities for a
“Right to First Review,” before any publication or pres-
entation of these results to the public, due to the poten-
tial sensitivity of some of the species that may be
discovered. Protocols will follow internationally recog-
nized standards for quality control and sequencing rigor
from the US Food and Drug Administration’s (FDA) Se-
quencing Quality Control Consortium (SEQC) and the
Earth Microbiome Project (EMP) as outlined above. Any
species discovered that are germane to bioterrorism or
public health will be turned over to public health officials
first and not reported without independent validation.
Finally, the ability to “mine” the metagenomic bio-
logical data for new drugs, small molecules, and antibi-
otics brings additional possibilities for innovation, but
also complications (Fig. 3). Since each country has their
own guidelines surrounding intellectual property (IP),
ownership of biological data, and also the regulations
around “bio-prospecting,” care must be taken to ensure
that national and international guidelines for collection
are met. Most current legislation around the world de-
fine “prospecting” as the collection of samples and re-
moval from the country of origin but likely do not apply
to the ability to predict the unique molecules of each
country from sequence data alone. To ensure that data
accessibility and attribution is maintained, and to avoid
the issues with rampant patenting of nucleic acids [45],
we are posting data from the consortium and ensuring
BGC first-pass detection as a component of standard
QC for each sample.
Fig. 2 Map of active MetaSUB sites. We have shown all the sites of
the MetaSUB International Consortium that are collecting. The sizes
of the circles are proportional to the number of riders per year on
the subway or mass-transit system
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Study design and goals
The final part of the meeting was to define the goals of
the MetaSUB consortium, which is now planned for at
least five years (2016–2020) and rooted in five core areas:
collection, analysis, design, standards, and education.
Collection
Establishing a coordinated, global data collection is
slated to begin on June 21, 2016, to match and parallel
the Global Ocean Sampling Day (OSD) [46, 47]. The will
begin the seasonal of cities around the world for the
next five years, matching at least the once-a-year fre-
quency of (OSD), but each season if possible for each
city. Notably, this time frame overlaps both the Brazilian
and Japanese Olympics, generating the profile of a city’s
“olympiome,” representing a first-ever sampling of cities
before, during, and after a global human migration
event. Sampling will be done to include: air in public
parks, surfaces in subway or transit system kiosks, park
water fountains, and adjacent ocean water (through
OSD). Also, a subset of 50 samples will undergo some
single-cell and cross-linked read capture (Hi-C), and long-
read sequencing for improved species resolution. Sam-
pling will focus on areas of mass transit, but other areas
throughout the city will be considered in order to paint a
clearer molecular portrait of the city and explore potential
networks and feedback mechanisms that may exist.
Analysis
There will be ongoing work for testing, sharing, and ad-
vancing computational methods. Also, we will link to
and curate a global database of detected BGCs as well as
antimicrobial resistance (AMR) markers. We will also
use rarefaction plots and Shannon diversity indices to
create cross-kingdom (plant, animal, bacterial, viral)
measures of diversity between climates and cities. Fi-
nally, we will look for any evidence of horizontal gene
transfer (HGT) in the samples when comparing to newly
sequenced genomes from local areas.
Design
These methods of collection that characterize many
types of surfaces may have an impact on future designs
and types of transit systems. There, collections include
samples from many types of surfaces, including plastic,
cloth, metal, ceramic, glass, and stone. In addition, we
will collect metadata about temperature, humidity, vola-
tile organic carbons (VOCs), air components, and other
Fig. 3 Discovery of biosynthetic gene clusters from surface-based metagenomics sampling. Plotting the density of organisms across the city
shows many diverse sites from which new biology could be discovered red to purple from highest to lowest); plotted here is the Pseudomonas
genus, and examples of three samples from the NYC PathoMap study: PAB009 (stairway railing), PAB03 (payphone), and PAB07 (sign). b Three
predicted BGCs discovered in the corresponding samples shown in a. Interestingly, these three BGCs are predicted to encode known and novel
small molecules of the thiopeptide/thiocillin class of antibiotics.
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environmental parameters. A long-term goal of the con-
sortium would be to design surfaces to enhance the
“good bacteria” present such that they could out-
complete the “bad bacteria” and make the surfaces better
for human occupancy and transit.
Standards
By deploying and testing DNA and bioinformatics stan-
dards, we will help improve methods in the field of
metagenomics. Specifically, we will continue to use sam-
ples with known proportions of species for in silico
measurement and testing of algorithms [1]. Also, we will
use Genome Reference Consortium (GRC) and US Na-
tional Institute of Standards and Technology (NIST)
standards for future testing of sequencing methods. Fi-
nally, we will plan to develop synthetic oligonucleotides
for positive controls during sampling to address the
question of DNA/RNA bias during collection.
Education
Using our methods for outreach, education, and hands-
on training is one of the key components of the consor-
tium. We have already engaged hundreds of students in
cities associated with the MetaSUB Consortium study,
and we intend to maintain this educational component.
This will include some citizen science outreach for high
school, college, graduate, and medical students, as well
as credits for a related course (microbiology, ecology,
genetics, genomics) during the sampling expeditions
(“swabventure”). Also, we have started a study abroad
and lab exchange program so that members of the Con-
sortium can visit each other’s labs and sites to learn about
genomics, informatics, or architecture. Indeed, we already
have three artists in residence for the Consortium, all of
whom work to visualize the microscopic and metagenomic
world around us. Finally, we will build a program to enable
a certificate of molecular microscopy, ideally as a free,
online course for people to take in their own country.
Community outreach
Along with the educational goals, MetaSUB seeks to
interact with local communities, teaching others to ex-
plore the microbiome that lives in us, on us, and all
around us [46]. We believe in the freedom of informa-
tion and feel that citizens are entitled to know about the
environment in which they live. We encourage citizens
to propose certain sites to be profiled, as well as encour-
age their involvement in the sampling process. Our Glo-
bal City Sampling Day (CSD) will be driven not only by
scientists in the consortium but open to all citizens in-
terested in exploring the molecular microbial and meta-
genomic dynamics of their cities and oceans (with OSD).
We also feel that it is important to provide easy access to
the data collected in a way that enables meaningful
interpretations by the general public. We hope that resi-
dents will have a role in disseminating and discussing the
results and that we will provide an additional metric with
which to understand and explore our urban environment.
Conclusion
Working together, we are building an unprecedented, glo-
bal metagenomics dataset and molecular portrait of the
urban microbiomes that we all share. Our collective efforts
aim to help current and future work in city planning,
urban design and architecture, transit systems, public
health, ecological studies, genome technologies, and im-
proved understanding of cities. We aim to use the lessons
of the preliminary studies to highlight the richness of the
microbial ecosystems of cities, train new students in best
practices and methods for metagenomics and microbiome
analysis, and ensure the greatest utility and benefit of these
data. These data will also provide a novel resource to dis-
cover new biochemical pathways, sources of antimicrobial
resistance, new methods of metagenomic design, and new
antibiotics that are created by the ecosystem of microbes
that have evolved to live among us (and we among them).
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